AU1566792A - New compounds for use in the treatment of cancer - Google Patents

New compounds for use in the treatment of cancer

Info

Publication number
AU1566792A
AU1566792A AU15667/92A AU1566792A AU1566792A AU 1566792 A AU1566792 A AU 1566792A AU 15667/92 A AU15667/92 A AU 15667/92A AU 1566792 A AU1566792 A AU 1566792A AU 1566792 A AU1566792 A AU 1566792A
Authority
AU
Australia
Prior art keywords
compound
electron
formula
hydroxymethyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15667/92A
Other languages
English (en)
Inventor
Michael Jarman
Ian Robert Judson
Derry Edward Vincent Wilman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Institute of Cancer Research: Royal Cancer Hospital
Original Assignee
The Institute of Cancer Research: Royal Cancer Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Institute of Cancer Research: Royal Cancer Hospital filed Critical The Institute of Cancer Research: Royal Cancer Hospital
Publication of AU1566792A publication Critical patent/AU1566792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU15667/92A 1991-03-22 1992-03-23 New compounds for use in the treatment of cancer Abandoned AU1566792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919106170A GB9106170D0 (en) 1991-03-22 1991-03-22 New compounds for use in the treatment of cancer
GB9106170 1991-03-22

Publications (1)

Publication Number Publication Date
AU1566792A true AU1566792A (en) 1992-10-21

Family

ID=10692068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15667/92A Abandoned AU1566792A (en) 1991-03-22 1992-03-23 New compounds for use in the treatment of cancer

Country Status (11)

Country Link
EP (1) EP0505220A1 (enExample)
JP (1) JPH06511229A (enExample)
AU (1) AU1566792A (enExample)
CA (1) CA2106868A1 (enExample)
GB (1) GB9106170D0 (enExample)
IE (1) IE920889A1 (enExample)
IL (1) IL101317A0 (enExample)
MX (1) MX9201258A (enExample)
TW (1) TW202437B (enExample)
WO (1) WO1992016513A1 (enExample)
ZA (1) ZA922073B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676677B2 (en) * 1992-03-27 1997-03-20 Cancer Research Campaign Technology Limited Melamine derivatives for use in the treatment of cancer

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219776D0 (en) * 1992-09-18 1992-10-28 Inst Of Cancer The Research New compounds for use in the treatment of cancer
JP2002509140A (ja) * 1998-01-13 2002-03-26 アナディーズ・ファーマスーティカルズ，インコーポレイテッド トリアジン抗ウイルス化合物
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
WO2009157628A1 (en) * 2008-06-23 2009-12-30 Industry-Academic Cooperation Foundation, Yonsei University Pharmaceutical composition for treating or preventing cancer comprising triazine compound as an active ingredient
CN101684115B (zh) * 2008-09-26 2011-12-21 上海医药工业研究院 4-(5-((2-(4-吗啉基-6-苯氨基-1,3,5-三嗪-2-基)亚肼基)甲基)呋喃-2-基)苯甲酸、其制备方法及用途
BR112015011213A2 (pt) * 2012-11-15 2017-08-29 Galleon Pharmaceuticals Inc Composto, composição farmacêutica, método de prevenção ou tratamento de um distúrbio ou doença de controle respiratório em um indivíduo, método de prevenção de desestabilização ou de estabilização do ritmo respiratório em um indivíduo, método de preparação de o,n-dimetil-n-[4-(n-propilamina)-6-(prop-2-inilamina)-[1,3,5]triazin-2-il]-hidroxilamina, e composição.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676677B2 (en) * 1992-03-27 1997-03-20 Cancer Research Campaign Technology Limited Melamine derivatives for use in the treatment of cancer

Also Published As

Publication number Publication date
CA2106868A1 (en) 1992-09-23
IE920889A1 (en) 1992-09-23
GB9106170D0 (en) 1991-05-08
TW202437B (enExample) 1993-03-21
ZA922073B (en) 1992-11-25
EP0505220A1 (en) 1992-09-23
MX9201258A (es) 1992-10-01
JPH06511229A (ja) 1994-12-15
IL101317A0 (en) 1992-11-15
WO1992016513A1 (en) 1992-10-01

Similar Documents

Publication Publication Date Title
AU713320B2 (en) Improved antiviral compounds
FI112477B (fi) Klooripyrimidiinivälituotteita, niiden valmistus ja menetelmä 2-aminopuriinien valmistamiseksi
US4658058A (en) 11-O-methylspergualin
EP1471920B1 (en) Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
US4658048A (en) Platinum complexes
US6559149B1 (en) Methotrexate derivatives
CA3035989A1 (en) Amino mercaptan compound and preparation method therefor and use thereof in protection against radiation
US5534625A (en) Melamine derivatives for use in the treatment of cancer
US12428414B2 (en) Methods for purifying isavuconazonium sulfate
WO1992016513A1 (en) New compounds for use in the treatment of cancer
EP0537575A1 (en) Hydrobromide of DC-89 derivative having antitumor activity
Jarman et al. Synthesis and cytotoxicity of potential tumor-inhibitory analogs of trimelamol (2, 4, 6-tris [(hydroxymethyl) methylamino]-1, 3, 5-triazine) having electron-withdrawing groups in place of methyl
CA1226295A (en) Glycolic acid type platinum complexes
EP0631583A1 (en) Antiviral phosphonic acid derivatives of purine analogues
CN114450278A (zh) 一个烟醇醚衍生物的马来酸盐及其晶型和应用
EP0654473B1 (en) Cyclopropane derivatives and antiviral agents containing the same
FI57589B (fi) Foerfarande foer framstaellning av blodtrycket saenkande 6-substituerade 3-karbetoksihydrazinopyridaziner
FI114024B (fi) Menetelmä terapeuttisesti käyttökelpoisten tioksantenonijohdannaisten valmistamiseksi
DE3889993T2 (de) 2'-Deoxy-5-fluorouridin-Derivate.
US3049542A (en) Diazomethyltriazine derivatives
WO1994006781A1 (en) New compounds for use in the treatment of cancer
EP0177728B1 (en) Arphamenine derivatives, a process for their preparation and their use as medicament
Ainley et al. THE TRYPANOCIDAL ACTIVITY OF SOME PYRIMIDYL‐AMINOPHENYLARSONIC COMPOUNDS
US20250295636A1 (en) Method for preparing 4-[5-[bis(2-chloroethyl)amino]-1-methyl-1h-benzo[d]imidazol-2-yl]butyric acid alkyl esters and formylated derivatives
JPH066578B2 (ja) チアゾリジン誘導体